Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Caris Life Sciences® announced it has acquired Pharmatech, a developer of the original Just-In-Time research system with the largest research-ready oncology network.
read more
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA, Darmstadt, Germany, which operates its healthcare business as EMD Serono in the U.S. and Canada, to ...
read more
Friday, September 01, 2017
Albany Molecular Research announced the completion of its previously announced acquisition by affiliates of The Carlyle Group and affiliates of GTCR.
read more
Piramal and The Carlyle Group announced CA Clover Intermediate II Investments has agreed to invest fresh equity capital for a 20% stake in Piramal Pharma that will contain its pharmaceutical businesses.
read more
Carmell Therapeutics recently held a pre-IND meeting with the FDA, advancing the company's clinical and regulatory strategies and driving the company's need to expand its manufacturing facilities.
read more
CARsgen Therapeutics announced the opening of its new manufacturing facility in Shanghai.
read more
Cartherics Pty Ltd and Catalent have signed an amended commercial license agreement enabling the use of a Catalent cGMP compliant induced pluripotent stem cells (iPSC) line for the manufacture and commercialization of Cartherics’ iPSC-derived ...
read more
Friday, February 19, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more
Monday, February 22, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more
Cascade Chemistry has been selected to produce the active pharmaceutical ingredient (API) for clinical trial supplies of RBT-9.
read more
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the ...
read more
Castor, a health-tech company that helps medical researchers maximize the value of research data, has annouonced its international business expansion. By strengthening its presence in the US and the EU, Castor is enabling more researchers and ...
read more
Catalent announced the BSI has awarded Catalent a global accreditation against the international management standards for environment and Occupational Safety.
read more
Monday, November 28, 2016
Catalent has agreed to acquire Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels. Financial details of the transaction have not been ...
read more
Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA, including its 32,400 square-foot facility in Gosselies, Belgium.
read more